Company Filing History:
Years Active: 2017-2019
Title: Innovations by Megan M Davis
Introduction
Megan M Davis is an accomplished inventor based in Nuangola, Pennsylvania. She has made significant contributions to the field of immunology through her innovative work on artificial antigen presenting cells. With a total of two patents to her name, her research has the potential to impact therapeutic strategies for T cell activation and expansion.
Latest Patents
Megan's latest patents focus on novel artificial antigen presenting cells (aAPCs). These aAPCs comprise at least one stimulatory ligand and at least one co-stimulatory ligand, which specifically bind to cognate molecules on T cells. This interaction mediates the expansion of T cells, making the aAPC a powerful tool for therapeutic development. The invention allows for the design of 'off the shelf' aAPCs that can be readily utilized to expand T cells of interest. Additionally, these aAPCs can help identify the factors that mediate T cell growth and expansion, providing valuable insights for novel therapeutic approaches.
Career Highlights
Megan M Davis is affiliated with the University of Pennsylvania, where she continues her research and development in immunology. Her work has garnered attention for its innovative approach to enhancing T cell responses, which is crucial for developing effective treatments for various diseases.
Collaborations
Megan collaborates with notable colleagues, including James L Riley and Carl H June. Their combined expertise contributes to advancing research in the field of immunotherapy.
Conclusion
Megan M Davis is a pioneering inventor whose work on artificial antigen presenting cells holds promise for the future of immunotherapy. Her contributions to the field are significant and continue to inspire advancements in therapeutic strategies.